Sign in
Active, not recruitingNo phase

Transcranial Ultrasound Stimulation as a Neuromodulation Therapy for Craving and Relapse Behaviors in Alcohol Use Disorder.

Key facts

Who runs it
Shanghai Mental Health Center
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
40 people, planned
Started
20 Mar 2025
Expected to end
1 Jan 2027
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Shame TUS-vmPFC
  • Active TUS-vmPFC
Record updated
13 January 2026

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Education level of junior high school or above, capable of completing questionnaires and behavioral tests
  • Aged 18-60 years
  • Meet DSM-5 diagnostic criteria for Alcohol Use Disorder
  • No abnormal findings on physical examination
  • Agree to participate in follow-up assessments
  • No contraindications for MRI scanning

Who cannot take part

  • Prior tDCS or TMS treatment within the past 3 months
  • Contraindications for TMS therapy (e.g., intracranial metal implants, history of traumatic brain injury, skull defects, cardiac pacemakers, cardiovascular diseases, or epilepsy)
  • Severe somatic diseases or major organ dysfunction
  • Psychiatric disorders per DSM-5 criteria (e.g., schizophrenia, schizoaffective disorder, intellectual disability, autism spectrum disorder, dementia, memory impairment, or other cognitive disorders)
  • Have impaired intelligence (Intelligence Quotient<70)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to evaluate the efficacy of transcranial ultrasound stimulation in reducing cravings and preventing relapse in individuals with alcohol use disorders. Utilizing a double-blind design, participants will be randomly assigned to receive either active accelerated transcranial ultrasound stimulation or a sham treatment.

The 2 groups in the trial

  • Intervention groupTreatment being tested

    The active group will receive active transcranial ultrasound stimulation.

    Treatment: Active TUS-vmPFC

  • Control groupSham treatment, for comparison

    The sham group will receive shame transcranial ultrasound stimulation.

    Treatment: Shame TUS-vmPFC

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
13 January 2026